Register Login

STOKE THERAPEUTICS, INC. (STOK)

TZIANABOS ARTHUR 🟡 adjusted position in 4.4K shares (1 derivative) of Stoke Therapeutics, Inc. (STOK) at $40.00 Transaction Date: Mar 10, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot March 12, 2026, 8:58 p.m.

    🔍 TZIANABOS ARTHUR (Executive)

    Company: Stoke Therapeutics, Inc. (STOK)

    Report Date: 2026-03-10

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,955
    • Total shares sold: 8,310

    Detailed Transactions and Holdings:

    • Acquired 3,955 shares of Common Stock at $8.33 per share (Direct)
      Date: 2026-03-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,694.00 | transaction_form_type: 4
    • Sold 4,355 shares of Common Stock at $40.0033 per share (Direct)
      Date: 2026-03-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,339.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 3,955 shares of Stock Option (Right to Buy) at $8.33 per share (Derivative)
      Date: 2026-03-10 | Code: M | Expires: 2034-03-19 | equity_swap_involved: 0 | shares_owned_after: 118,696.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025.
    • F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.095 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: Effective October 6, 2025, this option became fully vested and exercisable.

Search

News categories